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Abstract 
Background and Aims 
There are limited data on safety and outcomes of colorectal endoscopic mucosal resection 
(EMR) in octogenarians (≥80 years old). We sought to review outcome data for patients aged 80 and over in a 
prospectively collected database of patients referred for large polyp removal. 
Methods 
We retrospectively evaluated a database of patients referred for large (≥20 mm) nonpedunculated polyp 
removal. For years 2000 to 2019, we compared the rates of follow-up, recurrence, adverse events, and 
synchronous neoplasia detection between younger patients and patients aged 80 and over.  
Results 
There were 167 patients ≥80 years old and 1686 <80 years. Patients in the elderly group returned for 
surveillance less often (67.1% vs 75.1%, p=0.024), had greater first follow-up recurrence rates (27.5% vs 
13.8%, p<0.001) but had similar adverse event rates (1.8% vs 2.8%, p=0.619) compared with younger 
patients.  Rates of synchronous neoplasia were similar and high in both groups. 
Conclusion 
EMR is safe and well tolerated for large polyp removal in patients over 80 years old. Patients 
≥80 years of age are less likely to present for follow-up after EMR. They had a higher recurrence rate and a 
similarly high prevalence of synchronous precancerous lesions. Follow-up after EMR should be encouraged 
in the elderly, and an attempt to clear the colon of synchronous disease at the time of the initial EMR may be 
warranted.  
_______________________________________________
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Endoscopic mucosal resection (EMR) is the first-line treatment for large sessile and flat 
colorectal lesions 1-6. The prevalence of colorectal adenomas increases with age7, and colorectal 
cancer incidence increases sharply with age8. Advanced colorectal adenomas transform into 
cancer faster in the elderly than in younger persons9, 10, probably because they have accumulated 
more mutations. Patients ≥80 years of age are often found to harbor large nonpedunculated 
colorectal lesions, which are candidates for EMR. In our anecdotal experience, endoscopists may 
be fearful of adverse events in elderly patients, which might be poorly tolerated in the elderly. 
Our anecdotal experience is that some referring physicians only refer patients to our center for 
EMR who are elderly or who have serious comorbidities. This may reflect either unwillingness 
to perform colonoscopy and EMR in elderly patients, or perhaps referral of younger patients with 
large sessile and flat lesions for surgical resection11. Currently, EMR is the first-line treatment 
for large sessile or flat lesions in the colorectum in patients of any age12.  
There are limited data on the safety and outcomes of colorectal EMR in elderly patients13-17. 
Gomez et al13 reported the success and safety of colon EMR on 131 lesions ≥2 cm in size in 99 
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elderly patients but there was no control group under the age of 80. They noted many patients did 
not follow up for various reasons (eg, not being medically fit, death, or unknown reasons). Xie et 
al14 investigated the short-term outcomes of EMR in 63 lesions ≥2 cm in 46 patients ≥80 years 
old compared with patients <80 years old. Adverse event rates were similar in the 2 groups, but 
follow-up rates were not reported. 
We sought to evaluate the outcomes of EMR in older patients, with regard to efficacy 
(recurrence rates), adverse event rates, and follow-up surveillance rates. We also report 
synchronous neoplasia burden in older patients compared with patients <80 years old matched 
for gender and year of large polyp resection. 
Methods 
We retrospectively evaluated a database of patients referred for removal of large flat or sessile 
polyps. The database has been described elsewhere18. Th  database was collected prospectively 
and contains patient demographic information, polyp specific information, removal methods, 
adverse events and pathology. For the current study we included all patients in the database who 
had a nonpedunculated polyp ≥20 mm in size which was completely removed by snare resection 
(with ablation of residual flat or fibrotic lesion that resisted snaring in 2014 and prior and 
avulsion of flat lesion in 2015 and after) at index examination and did not have a submucosal 
invasion as indicated by pathology report. Ablation of flat or fibrotic residual polyp that resisted 
snaring was treated by argon plasma coagulation (APC) before 2015 and by avulsion using 
electrocautery (“hot avulsion”) from January 2015. The database also records information on up 
4 
 
to 4 follow-up examinations after polyp removal. During the follow-up examination, the 
endoscopist records any visible recurrence at the site of polypectomy, removes any residual 
lesion, and performs biopsies on those portions of the scar that are normal or have clip artifact. 
Any visible polyp tissue on the scar was deemed residual polyp, regardless of whether it was 
verified by pathology (electrocautery used to remove the recurrence sometimes destroys the 
recurrence). If the endoscopist did not see a recurrence but a biopsy from the scar revealed 
neoplastic tissue (adenoma or sessile serrated lesion), we counted that as recurrence as well. 
Adverse events included delayed bleeding (defined as hospitalization or requiring transfusion or 
repeat colonoscopy for managing bleeding symptoms after departing the endoscopy unit), and 
perforation. A return examination was defined as a colonoscopy examination at our center for 
examining the polypectomy site and clearing the remaining colon.  
 
Synchronous neoplasia 
For the purpose of calculating synchronous neoplasia burden, we included all neoplasia removed 
at the index colonoscopy (when EMR was performed) or at any follow-up examination within 1 
year of the index colonoscopy at our center. Among the 112 elderly patients with a follow-up 
examination, we identified 97 with a follow-up colonoscopy within a year of the index 
examination. We matched by gender, index polyp histology, and year of examination, 97 patients 
from the group of people less than 80 years old who also had a follow-up colonoscopy within a 
year of the index colonoscopy to compare synchronous neoplasia.  The number of synchronous 
lesions, therefore, reflects these selected 194 patients. We report number of patients with 
additional adenomas (ADR, adenoma detection rate; number of patients with ≥1 synchronous 
conventional adenoma divided by total number of patients), with additional advanced adenomas 
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(AADR, advanced adenoma detection rate; number of patients with ≥1 synchronous 
conventional advanced adenoma divided by total number of patients), and with additional sessile 
serrated lesions (SSLDR, sessile serrated lesion detection rate; number of patients with ≥1 
synchronous sessile serrated lesion divided by total number of patients). We defined advanced 




The chi-squared test was used to compare return rate for follow-up, the recurrence rate at follow-
up, rate of adverse events and rate of synchronous lesions for patients ≥80 years compared with 
patients <80 years of age. For comparing time to first follow-up and size of polyps among both 
groups we used the nonparametric Mann-Whitney test. We used the chi-squared test and Student 
t-test, respectively, to compare polyp detection rates and polyps per colonoscopy among the 
groups for synchronous neoplasia. We report 95% confidence intervals (CIs) for polyp detection 




During the study interval, 1852 patients underwent EMR of 2191 colorectal polyps. A total of 
1989 colonoscopies were performed for initial removal of large (≥20 mm) lesions (some patients 
had more than 1 lesion removed in a single colonoscopy and others had more than 1 lesion 
removed over multiple colonoscopies, with 184 colonoscopies in patients aged 80 years and over 
(Group A) and 1805 colonoscopies in patients under 80 years (Group B) . The average age of 
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Group A patients was 83.3 years (SD = 2.7) and Group B was 63.8 years (SD = 9.1) (p<0.001). 
Women comprised 55% of Group A and 48% of Group B (p = 0.115) (Table 1). Adverse events 
were similar in the 2 groups (1.8% in Group A vs 2.8% in Group B, p=0.480) (Table 1). There 
were 6 perforations in the younger group and none in the elderly. The majority of polyps 
removed in both groups were in the right colon segment (58% in Group A vs 61% in Group B, 
p=0.170) (Table 1). The percentage of patients who had a follow-up colonoscopy at our center 
was 67.1% in Group A and 75.1% in Group B (p=0.024). 
  
Among polyps with at least 1 follow-up examination, there was no difference between the 
groups for polyp size (mean size 29.7 mm and 29.9 mm in Group A and Group B, p=0.816). The 
prevalence of high-grade dysplasia (HGD) in the baseline lesions was 12.4% in the elderly and 
11.7% in the younger patients.  The median time to first follow-up was similar between the 
groups (6.05 vs 6.07 months, p=0.159). Residual polyp was present at first follow-up (in those 
presenting to our center) in 27.5% of resected polyps in Group A versus 13.8% in Group B 
(p<0.001) (Table 2). 
Before 2015, lesions with flat or fibrotic polyp that resisted snaring were treated by ablation with 
APC. Early in the experience, APC was used to treat all or part of the normal edge of the EMR 
defect in some lesions. Among 906 lesions treated through December 2014, there were no 
significant differences between the elderly and younger patients in use of APC, but APC use to 
treat flat residual polyp was numerically less likely in elderly patients (29% vs 33%) and APC 
use to treat all or part of the normal appearing rim of the EMR defect was numerically more 
likely in elderly patients (39% vs 28%). 
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Synchronous additional neoplasia burden in the elderly and the matched controls is shown in 
Table 3. Both groups had a high prevalence of synchronous or additional adenomas and sessile 
serrated lesions, and the rates were similar between the groups (Table 3).  
Discussion: 
In this report, we demonstrate that EMR in patients ≥80 years is associated with a higher 
recurrence rate but a similar rate of adverse events compared with EMR in patients <80 years, 
and elderly patients were less likely to return to our center for follow-up. The exact reasons for 
being less likely to return for follow-up are unclear, but could include factors such as more 
comorbidities, poor tolerance of prep, more difficulty arranging transportation from substantial 
distances, or a difference in patient attitude toward follow-up. Some patients, particularly those 
traveling significant distances to our center, could have undergone follow-up by their referring 
colonoscopist. However, given the size of the study, we expect the differences in follow-up rates 
are real. Xie et al14 also noted that substantial numbers of elderly patients did not undergo 
follow-up after EMR. Hence, our data suggest that special measures should be considered to help 
ensure that elderly patients undergo follow-up after EMR. Recent breakthroughs in EMR 
technique,19-22 such as application of snare tip soft coagulation thermal injury to the margin of 
the EMR defect, should result in lower recurrence rates and reduce the implications of lower 
follow-up rates after EMR in elderly patients. Rates of synchronous disease were similar to  
younger patients with large sessile or flat colorectal lesions and high in both groups (18). 
Because of lower rates of follow-up attendance and the high rate of synchronous disease, there is 
a rationale for clearing the colon of synchronous disease at the index examination in the elderly 
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whenever feasible, although this rationale is arguably in play for all patients with large 
nonpedunculated lesions. 
 
The higher recurrence rate at first follow-up in the elderly was not expected, although we did 
identify a prior study that reported age >70 years was an independent predictor of recurrence23. 
When we adjusted for histologic type (looking at adenomas only) and eliminating a small group 
of elderly patients whose lesions were removed without electrocautery (data not shown), the 
difference in recurrence and magnitude of difference persisted.  The reasons for this result are 
currently not clear. Previous reports found that HGD in the baseline lesion was a predictor of 
recurrence 3, 24. However, HGD prevalence was similar at baseline in the 2 groups in this study. 
Certain factors such as intraprocedural bleeding 25 and attempts at resection (with resultant 
fibrosis) 3 that might affect the risk of recurrence were not recorded in the database for much of 
the study interval. Thus, we are uncertain whether there were differences in these factors in the 
elderly. It is possible that we applied resection techniques less aggressively in the elderly, with 
the goal of reducing the adverse events, and because of fear of adverse events in the elderly. For 
example, until 2015, our usual practice was to ablate flat residual polyp with the argon plasma 
coagulator (APC). Since then, we have used hot avulsion rather than ablation26 because avulsion 
was shown in uncontrolled studies to be more effective than ablation of residual tissue27, 28. 
Anecdotally, the senior author’s impression is that APC ablation is generally associated with less 
risk of delayed hemorrhage compared with resection. Thus, any subconscious tendency to switch 
from snaring to ablation earlier during EMR (to reduce the risk of adverse events) in the elderly 
could increase the recurrence rate. However, we did not identify increased use of APC to treat 
residual polyp in the elderly before 2015. Thus, although we have no actual evidence to support 
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the suggestion that any technique we used for EMR differed in the elderly,  a subconscious bias 
with regard to technique could potentially have contributed to the differences in residual polyp 
rates. Because our study is a retrospective assessment of a database, it is possible that other 
unseen factors account for the recurrence difference.  It also seems possible, given that evidence 
indicates that advanced adenomas become cancer faster in the elderly9, 10, that some biologic 
differences in polyps in the elderly drive a higher recurrence rate, just as HGD is associated with 
a higher recurrence rate 3, 24 . Finally, as noted above, a previous study found that age >70 years 
was an independent predictor of recurrence 23. Thus, our finding of a higher recurrence rate in the 
elderly is not novel. Additional study and prospective evaluation of recurrence rates after EMR 
in the elderly are warranted. 
 
Limitations of our study include its retrospective nature. However, the database was accumulated 
prospectively. All of the EMRs were performed by a single endoscopic expert, which could limit 
the generalizability of the results. However, the large size of the study and the inclusion of 
control group for the prevalence of synchronous lesions are strengths of the study, and we expect 
that the results with regard to follow-up rates and synchronous disease are likely to be 
generalizable.  
 
Currently, EMR is the treatment of choice for large benign flat and sessile colorectal lesions. 
These results suggest that in patients age ≥80 years, where mortality from surgical resection is 
about 3% in the United States29, EMR is safe and well tolerated. Because of higher recurrence 
rates, lower follow-up rates, and higher rates of synchronous neoplasia, special measures are 
appropriate to encourage follow-up in patients age ≥80 years undergoing EMR. When feasible, 
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patients undergoing EMR at referral centers should have their colons cleared of synchronous 
disease at the index examination, particularly if they are elderly.  
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Table 1. Patient and polyp characteristics among patients undergoing EMR 
≥80 years, n=167* <80 years, 
N=1686 
P value 
Women, n (%) 91 (54.5) 811 (48.1) .115 
Mean age, years (SD) 83.3 (2.7) 63.8 (9.1) <.001 
No. of examinations, no. of polyps 184, 210 1805, 1981 
Location of the polyps, n (%) 
Left colon segment 
Transverse colon (includes hepatic and 
splenic flexures) 








Pathology of polyps, n (%) 
Adenomatous 



















Patients with at least one follow-up 
examination, n (%) 
112 (67.1) 1266 (75.1) .024 
EMR, Endoscopic mucosal resection; SD, standard deviation. 
* One patient is included in both groups as they had a large polyp removed when they were




Table 2. Characteristics of polyps with a follow-up examination 
 
 




 Polyps among 
persons ≥ 80 years 
old 
Polyps among persons  
<80 years old 
P value 
N 142 1486  
Median time to first follow-up 
examination, months (minimum-
maximum) 
6.05 (2-59) 6.07 (0.8-178) .159* 
Mean size, mm (SD) 29.7 (10.1) 29.9 (11.3) .716* 
Residual polyp present at first 
follow-up examination, n (%) 
39 (27.5) 205 (13.8) < 0.001 
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Table 3. Synchronous lesions in patients ≥ and under 80 years 
Patients ≥80 years, n=97 Patients less than 80 
years, n=97* 
P value 
ADR, n (%, 95% CI) 83 (85.6, 77.6-91.5) 78 (80.4, 71.7-87.4) .339 
APC, µ (SD)  5.02 (5.88)  4.58 (6.71) .625 
AADR, n (%, 95% 
CI) 
 46 (47.4, 37.7-57.3)  35 (36.1, 27.0-45.9) .109 
AAPC, µ (SD)  1.12 (2.04)  0.88 (1.87) .380 
SSLDR, n (%, 95% 
CI) 
 11 (11.3, 6.2- 18.8)  11 (11.3, 6.2-18.8) 1.000 
SSLPC, µ (SD)  0.22 (0.74)  0.37 (1.19) .279 
AADR, Advanced adenoma detection rate; AAPC, advanced adenomas per colonoscopy; ADR, 
Adenoma detection rate; APC, adenomas per colonoscopy; CI, confidence interval; SD, standard 
deviation; SSLDR, sessile serrated lesions detection rate; SSLPC, sessile serrated lesions per 
colonoscopy. 
*Matched with patients ≥80 years group for gender, index polyp histology, and year of
examination.
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